| Michael Erdil, MD | |
|
2 Mount Royal Ave Ste 410, Marlborough, MA 01752-1976 | |
| (508) 251-7260 | |
| (508) 251-7265 |
| Full Name | Michael Erdil |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
| Location | 2 Mount Royal Ave Ste 410, Marlborough, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194894154 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Erdil, MD 2 Mount Royal Ave Ste 410, Marlborough, MA 01752-1976 Ph: (508) 251-7260 | Michael Erdil, MD 2 Mount Royal Ave Ste 410, Marlborough, MA 01752-1976 Ph: (508) 251-7260 |
News Archive
These bills will provide a bedrock sense of security and stability for Americans who have health insurance, and quality, affordable options for Americans without it (Peter R. Orszag, 11/20).
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted against the following question: "Based on the current available data, do you believe the overall benefit-risk assessment of PHEN/TPM (QNEXA) is favorable to support its approval for the treatment of obesity in individuals with a BMI > 30 kg/m2 or > 27 kg/m2 with weight-related co-morbidities?" The three co-morbidities included hypertension, diabetes and dyslipidemia.
athenahealth, Inc., a leading provider of cloud-based practice management, electronic health record (EHR), and care coordination services to medical groups, and Sermo, the world's largest online community for physicians, today announced the findings from the third annual Physician Sentiment Index (PSI).
Four Senators addressed the hundreds of home care and hospice providers today that have come to our nation's capitol to keep the fight alive for the critical, high-value, high-quality care that is offered to millions of vulnerable citizens in this country.
About one in eight women in the United States will contract breast cancer in her lifetime. Now new research from Tel Aviv University-affiliated researchers, in collaboration with Johns Hopkins University, has provided another tool to help women, clinicians, and scientists searching for a cure to the one of the most widespread yet incurable diseases on the planet.
› Verified 4 days ago